Bergan Kdv Wealth Management, LLC Abbott Laboratories Transaction History

Bergan Kdv Wealth Management, LLC

$999 Million
Q2 2023

A detailed history of Bergan Kdv Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 31,550 shares of ABT stock, worth $3.58 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

31,550

Previous 30,788 2.47%

Holding current value

$3.58 Million

Previous $3.12 Million 10.33%

% of portfolio

0.34%

Previous 0.32%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $76,794 - $85,564	762 Added 2.47%	31,550 $3.44 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $13,463 - $15,847	139 Added 0.45%	30,788 $3.12 Million
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $10,931 - $12,824	115 Added 0.38%	30,649 $3.37 Million
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $14,320 - $16,580	148 Added 0.49%	30,534 $2.95 Million
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $88,596 - $107,085	-868 Reduced 2.78%	30,386 $3.3 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $599,061 - $730,516	-5,254 Reduced 14.39%	31,254 $3.7 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $187,043 - $229,023	-1,619 Reduced 4.25%	36,508 $5.14 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $149,441 - $165,325	1,281 Added 3.48%	38,127 $4.5 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $274,948 - $323,653	-2,599 Reduced 6.59%	36,846 $4.27 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $23,509 - $27,697	-216 Reduced 0.54%	39,445 $4.73 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $210 - $228	2 Added 0.01%	39,661 $4.34 Million
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $26,117 - $31,717	-285 Reduced 0.71%	39,659 $4.32 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $901,841 - $1.15 Million	-11,778 Reduced 22.77%	39,944 $3.65 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $7,915 - $11,574	126 Added 0.24%	51,722 $4.08 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $5,417 - $6,030	69 Added 0.13%	51,596 $4.48 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $40,920 - $44,370	-500 Reduced 0.96%	51,527 $4.31 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $723,771 - $844,135	9,931 Added 23.59%	52,027 $4.38 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $2.5 Million - $3.02 Million	37,746 Added 867.72%	42,096 $3.37 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $1,033 - $1,247	-17 Reduced 0.39%	4,350 $319,000
Q2 2018 Jul 23, 2018	BUY	$57.57 - $63.54 $5,354 - $5,909	93 Added 2.18%	4,367 $266,000
Q1 2018 May 03, 2018	SELL	$56.27 - $63.62 $234,308 - $264,913	-4,164 Reduced 49.35%	4,274 $256,000
Q4 2017 Jan 16, 2018	BUY	$53.68 - $57.47 $177,251 - $189,765	3,302 Added 64.29%	8,438 $482,000
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $246,836 - $275,495	5,136	5,136 $274,000

Others Institutions Holding ABT

# of Institutions

3,162

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.

Account

Bergan Kdv Wealth Management, LLC Abbott Laboratories Transaction History